P-glycoprotein-mediated efflux transport of anticancer drugs at the blood-brain barrier

Therapeutic Drug Monitoring

Volumn 20, Issue 5, 1998, Pages 588-590

  Tsuji, Akira ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Anticancer drug; Blood brain barrier; Brain delivery; Brain tumor; Efflux; P glycoprotein; Transporter

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON 14; CHLORPROMAZINE; CYCLOSPORIN A; DIGOXIN; DILTIAZEM; DOXORUBICIN; GLYCOPROTEIN P; IVERMECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MRK 16; PROTEIN INHIBITOR; QUINIDINE; RANIMUSTINE; STEROID HORMONE; SUCROSE; TRITIUM; UNCLASSIFIED DRUG; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCRISTINE; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CAPILLARY ENDOTHELIUM; CONFERENCE PAPER; DRUG PENETRATION; DRUG TRANSPORT; ENDOTHELIUM CELL; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM, VASCULAR; HUMANS; P-GLYCOPROTEIN;

EID: 0031691947     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199810000-00024     Document Type: Conference Paper

References (20)

1. Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989;86:695-8.
2. Cornford EM. The blood-brain barrier, a dynamic regulatory interface. Mol Physiol 1985;7:219-60.
3. Levin VA. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 1980;23:682-4.
4. Pardridge WM. Transport of small molecules through the blood-brain barrier: Biology and methodology. Adv Drug Deliv Rev 1995;15:5-36.
5. Tamai I, Tsuji A. Pharmacokinetics in drug delivery systems: Drug delivery through the blood-brain barrier. Adv Drug Deliv Rev 1996;19:401-24.
6. Tsuji A, Tamai I. Blood-brain barrier function of P-glycoprotein. Adv Drug Deliv Rev 1997;25:287-98.
7. van Asperen J, Mayer U, van Tellingen O, et al. The functional role of P-glycoprotein in the blood-brain barrier. J Pharm Sci 1997; 86:881-4.
8. Tsuji A, Terasaki T, Takabatake Y, et al. P-glycoprotein as the drug efflux pump in primary cultured brain capillary endothelial cells. Life Sci 1992;51:1427-37.
9. Tsuji A, Tamai I, Sakata A, et al. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem Pharmacol 1993;46:1096-9.
10. Tatsuta T, Naito M, Oh-hara T, et al. Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 1992;267: 20383-91.
11. Shirai A, Naito M, Tatsuta T, et al. Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim Biophys Acta 1994;1222:400-04.
12. Ohnishi T, Tamai I, Sakanaka K, et al. In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. Biochem Pharmacol 1995; 49:1541-4.
13. Sakata A, Tamai I, Kawazu K, et al. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol 1994;48:1989-92.
14. Drin N, Lemaire M, Lefauconnier L-M, et al. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine. J Neurochem 1996;67:1688-93.
15. Schinkel AH, Smit JJM, van Tellingen O, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994;77:491-502.
16. Schinkel AH, Wagenaar E, van Deemter L, et al. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995;96:1698-1705.
17. Schinkel AH, Wagenaar E, van Deemter L, et al. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacologic activity of many drugs. J Clin Invest 1996;97: 2517-24.
18. Schinkel AH, Mayer U, Wagenaar E, et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 1997;94: 4028-33.
19. Yamashima T, Ohnishi T, Nakajima Y, et al. Uptake of drugs and expression of P-glycoprotein in the rat 9L glioma. Exp Brain Res 1993;95:41-50.
20. Oldendorf WH. Measuremente of brain uptake of radiolabeled substrates using a tritiated water internal standard. Brain Res 1970; 24:372-6.